Clinical trial
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
NCT03084718
Study timeline
Study start (actual)2017-07-28Date precision: day
Registry last updated2021-12-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
Sponsors & collaborators
Chiesi Farmaceutici S.p.A.lead sponsor
Mapped research locations
MiamiFlorida, United States5Los AngelesCalifornia, United States3New YorkNew York, United States2ChicagoIllinois, United States2DallasTexas, United States2St LouisMissouri, United States2CincinnatiOhio, United States2San DiegoCalifornia, United States2Las VegasNevada, United States2CharlotteNorth Carolina, United States2AlbuquerqueNew Mexico, United States2DaytonOhio, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03084718 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.